Evolution of the Average Target: Albemarle Corporation

Evolution of the Target Price: Albemarle Corporation

Changes in Analyst Recommendations: Albemarle Corporation

ddc0571f6168aadf2ea.0kJ5Sa1f6Rhl5Yg2VCh_Sim1zBJl8HNrlI70_sK6sgs.qCk4C-c9p0kGhuJ4IGMUM1iCp0NIliZaoemiu6DA_jKjOhUg5SmuVCvc4w~bcdce75a5faf869c3a4faeae51984535
Jan. 13 Analyst recommendations: Albemarle, Five Below, Live Nation, Mastercard, Moody's…. Zonebourse
Jan. 13 Deutsche Bank Upgrades Albemarle to Buy From Hold, Adjusts Price Target to $185 From $125 MT
Jan. 12 UBS Adjusts Price Target on Albemarle to $205 From $185, Maintains Buy Rating MT
Jan. 12 Jefferies Adjusts Price Target on Albemarle to $210 From $167, Maintains Buy Rating MT
Jan. 12 Scotiabank Upgrades Albemarle to Sector Outperform From Sector Perform, Adjusts Price Target to $200 From $85 MT
Jan. 09 S&P 500 Climbs in First Full Week of 2026, Hits New Highs MT
Jan. 08 BofA Securities Adjusts Albemarle Price Target to $167 From $118, Maintains Neutral Rating MT
Jan. 07 Albemarle Shares Rise After Baird Upgrade MT
Jan. 07 Baird Upgrades Albemarle to Outperform From Neutral, Adjusts Price Target to $210 From $113 MT
Jan. 06 Berenberg Raises Price Target on Albemarle to $135 From $75, Keeps Hold Rating MT
Jan. 05 Jefferies Adjusts Price Target on Albemarle to $167 From $152, Maintains Buy Rating MT
Dec. 19 Wells Fargo Adjusts Price Target on Albemarle to $135 From $100, Maintains Equalweight Rating MT
Dec. 18 Mizuho Securities Adjusts Albemarle Price Target to $132 From $110, Maintains Neutral Rating MT
Dec. 18 Citigroup Adjusts Albemarle Price Target to $150 From $100, Maintains Neutral Rating MT
Dec. 18 RBC Boosts Price Target on Albemarle to $159 From $120, Keeps Outperform Rating MT
Dec. 18 Analyst recommendations: American Express, Merck, Rivian, Albemarle, Micron… Zonebourse
Dec. 16 Morgan Stanley Upgrades Albemarle to Equalweight From Underweight, Adjusts PT to $147 From $58 MT
Dec. 16 Analyst recommendations: Accenture, Albemarle, Eli Lilly, Gitlab, Okta… Zonebourse
Dec. 15 BMO Capital Adjusts Price Target on Albemarle to $145 From $136, Maintains Outperform Rating MT
Dec. 08 Jefferies Adjusts Price Target on Albemarle to $152 From $124, Maintains Buy Rating MT
Dec. 05 Albemarle Shares Rise After UBS Upgrade MT
Dec. 05 UBS Upgrades Albemarle to Buy From Neutral, Adjusts Price Target to $185 From $107 MT
Dec. 04 Rothschild & Co Redburn Adjusts Price Target on Albemarle to $158 From $135, Maintains Buy Rating MT
Dec. 03 Deutsche Bank Adjusts Price Target on Albemarle to $125 From $110, Maintains Hold Rating MT
Dec. 02 Analyst recommendations: Albemarle, Dexcom, T-Mobile, Alphabet, Micron… Zonebourse
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-19.57%
+6.92%
+22.62%
+33.13%
+22.22%
-15.85%
+4.69%
+0.51%
+31.75%
-2.74%
Average +8.37%
Weighted average by Cap. +9.59%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
177.55USD
Average target price
142.79USD
Spread / Average Target
-19.57%
High Price Target
210.00USD
Spread / Highest target
+18.28%
Low Price Target
80.00USD
Spread / Lowest Target
-54.94%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Deutsche Bank Securities
UBS
Jefferies & Co.
Scotiabank
BofA Securities
Baird
Berenberg Bank
Wells Fargo Securities
Mizuho Securities
Citigroup
RBC Capital Markets
Morgan Stanley
BMO Capital
Rothschild & Co Redburn
HSBC
Argus
Evercore ISI
Vertical Research
DBS Bank
TD Cowen
JPMorgan Chase
Oppenheimer
KeyBanc Capital Markets
Truist Securities
Piper Sandler
Credit Suisse
Cowen
Goldman Sachs
Loop Capital
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
177.55USD
Average target price
142.79USD
Spread / Average Target
-19.57%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALB Stock
  4. Consensus Albemarle Corporation